Skip to main content
. 2020 Oct 19;2020(10):CD004730. doi: 10.1002/14651858.CD004730.pub5

Comparison 4. NPH insulin versus glargine.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
4.1 Glucose levels (mg/dl) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1.1 Fasting (at 3 months) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1.2 2 hour post‐prandial (at 3 months) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.2 Change in weight (kg) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.2.1 At 3 months 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.3 Fat mass by DEXA (kg) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.3.1 At 3 months 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.4 Lean mass by DEXA (kg) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.4.1 At 3 months 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.5 Hypoglycemic events per participant 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.5.1 At 3 months 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected